Back to results
US 2024/0182858 A1Published application
Pericyte having basic fibroblast growth factor (bfgf) gene introduced therein
AssigneesAstellas Pharma Inc., Osaka University
InventorsKenichiro SHIMATANI, Hiromu SATO, Masao SASAI, Yoshiki SAWA, Atsuhiro SAITO, Shigeru MIYAGAWA
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide a cell therapy that is expected to be useful as an angiogenic therapy for a peripheral vascular disease such as critical lower limb ischemia. Specifically, the object is to provide a pericyte having high angiogenic potential and a method for producing the same. A pericyte introduced a bFGF gene and a method for producing the same are provided.
Claims15
A pericyte into which a basic fibroblast growth factor (bFGF) gene has been introduced.
(canceled)
(canceled)
15-18. (canceled)
Dependencies are inferred from the claim text.